The Tamil Nadu Directorate of Drugs Control has taken swift action against a potentially dangerous children's medicine. Authorities have issued an alert and imposed a complete ban on a specific batch of Almont-Kid Syrup.
Immediate Ban and Withdrawal Ordered
State drug control officials have prohibited the sale, purchase, and consumption of Batch No AL-24002. This batch was manufactured by Tridus Remedies, a company based in Bihar. The directive mandates the immediate withdrawal of this syrup from all pharmacies and hospitals across Tamil Nadu.
Toxic Chemical Discovery
Laboratory tests conducted on the syrup revealed the presence of ethylene glycol. This toxic chemical is a known contaminant that can cause serious health issues, especially in children. The discovery prompted the urgent regulatory response from the state authorities.
Deputy Director of Drugs Control, S Gurubarathi, provided clarification on the situation. He stated that there was no supply of this particular drug batch within Tamil Nadu at the time of the alert. This suggests the ban is a preventive measure to ensure public safety.
New National Standards Trigger Action
This regulatory move follows recent amendments to national drug safety norms. In October 2025, the Indian Pharmacopoeia Commission implemented stricter requirements. The new mandate requires testing for ethylene glycol and diethylene glycol in all oral liquid medications.
The nationwide tightening of standards aims to prevent contamination in medicines. Tamil Nadu's action demonstrates the state's commitment to enforcing these updated safety protocols. It shows how regional authorities are responding to central directives to protect consumers.
Parents and caregivers should check any Almont-Kid Syrup they possess. They must verify it is not from the banned batch number AL-24002. Medical professionals have been instructed to cease dispensing this specific batch immediately.
